BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9723410)

  • 1. Treatment of bone pain after kidney transplantation.
    Grotz W; Rump JA; Niessen A; Schmidt-Gayk H; Schollmeyer P
    Transplant Proc; 1998 Aug; 30(5):2114-6. PubMed ID: 9723410
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of osteopenia and osteoporosis after kidney transplantation.
    Grotz WH; Rump LC; Niessen A; Schmidt-Gayk H; Reichelt A; Kirste G; Olschewski M; Schollmeyer PJ
    Transplantation; 1998 Oct; 66(8):1004-8. PubMed ID: 9808483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
    Hershman D; Narayanan R
    Curr Oncol Rep; 2004 Jul; 6(4):277-84. PubMed ID: 15161581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.
    Valero MA; Loinaz C; Larrodera L; Leon M; Moreno E; Hawkins F
    Calcif Tissue Int; 1995 Jul; 57(1):15-9. PubMed ID: 7671159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates.
    Schapira D; Braun Moscovici Y; Gutierrez G; Nahir AM
    Clin Exp Rheumatol; 2003; 21(1):107-10. PubMed ID: 12673900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M
    Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of bone mineral density in renal transplantation recipients.
    Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
    Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Densitometric threshold and vertebral fractures in heart transplant patients.
    Dalle Carbonare L; Zanatta M; Braga V; Sella S; Vilei MT; Feltrin G; Gambino A; Pepe I; Rossini M; Adami S; Giannini S
    Transplantation; 2011 Jul; 92(1):106-11. PubMed ID: 21694501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcitonin therapy on osteoporosis in patients with thalassemia.
    Canatan D; Akar N; Arcasoy A
    Acta Haematol; 1995; 93(1):20-4. PubMed ID: 7725845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clodronic acid in the treatment of postmenopausal osteoporosis.
    Tanakol R; Yarman S; Bayraktaroglu T; Boztepe H; Alagöl F
    Clin Drug Investig; 2007; 27(6):419-33. PubMed ID: 17506592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term clodronate treatment does not increase trabecular bone in posttraumatic osteopenia.
    Nyman MT; Paavolainen P; Lauren L; Arnala I
    Ann Chir Gynaecol; 1995; 84(3):296-301. PubMed ID: 8702205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX; Li H
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorder of mineral density of the bone tissue in patients with chronic pancreatitis].
    Chernyshova IV; Drozdov VN; Vinokurova LV; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2008; (7):29-32. PubMed ID: 19334441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
    Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
    Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology and therapy of localized osteopenia].
    Montagnani M; Gennari C
    Minerva Med; 1991; 82(1-2):1-8. PubMed ID: 2000166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone metabolism alterations after kidney transplantation].
    Torres A; García S; Barrios Y; Hernández D; Lorenzo V
    Nefrologia; 2003; 23 Suppl 2():122-6. PubMed ID: 12778868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.
    El-Husseini AA; El-Agroudy AE; El-Sayed MF; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2004 Aug; 8(4):357-61. PubMed ID: 15265162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.